Dialysis delayed is death prevented: A clinical perspective on the RENAAL study
Open accessIntegrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The effect of blood-pressure reduction on cardiovascular end points usually occurs within months, whereas the effect of lipid lowering is evident after 1 to 2 years.
“The effect of blood-pressure reduction on cardiovascular end points usually occurs within months, 26,27 whereas the effect of lipid lowering is evident after 1 to 2 years.8,28,29”
From Effect of a multifactorial intervention on mortality in type 2 diabetes (2008) · cites this paper as [27]
Cites
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,489 · see citing works
Levey, A. S., Inker, L. A., Matsushita, K., Greene, T., Willis, K., Lewis, E., de Zeeuw, D., Cheung, A. K., & Coresh, J. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.07.030 · Cited by 620 · see citing works
- Authors
- Thomas, M. C., Cooper, M. E., Shahinfar, S., & Brenner, B. M.
- Corresponding author
- Thomas, Merlin C.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2003-04
- Volume
- 63
- Issue
- 4
- Pages
- 1577-1579
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2068868772
- Cited by
- 22
- References
- 1
- Citations by year
- 2022: 2 · 2021: 1 · 2018: 1 · 2016: 2 · 2014: 3 · 2013: 1
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Kidney International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- RENAAL trial, renin-angiotensin system blockade, renin-angiotensin-aldosterone system inhibitors, chronic kidney disease, end-stage renal disease, renal death, dialysis, clinical trial endpoints, treatment efficacy
- MeSH terms
- Developing Countries, Humans, Kidney Failure, Chronic, Global Health, Renal Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
